ERBB2 and breast cancer: This work seeks to characterize the metabolic reprogramming related to tumor dormancy and recurrence in a Her2+/Neu model of breast cancer and to identify differences in tumors that rapidly recur, modeling a highly aggressive phenotype, or tumors that persist in dormancy for a longer period of time prior to recurrence.